Pharmaceutical major Strides Acrolab has announced that it has received regulatory sanction for two of its drugs used in the treatment of potentially life-threatening infections.

According to sources, the conglomerate has got approval from US Food and Drug Administration for Sterile Vancomycin in two different capacities.

The products are licensed to Akron-Strides LLC, which is a joint venture between Akron Inc and Strides Arcolab.